Market Tracker

03/03 6:53am ET

Myriad Genetics Inc (NASDAQ:MYGN)

33.49
Delayed Data
As of Mar 02
 -0.58 / -1.70%
Today’s Change
31.56
Today|||52-Week Range
42.50
-1.67%
Year-to-Date

Today’s Trading

Previous close34.07
Today’s open34.01
Day’s range-- - --
Volume934,726
Average volume (3 months)916,870
Market cap$2.4B
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.29%
Earnings growth (next 5 years)+13.75%
Revenue growth (last year)+26.92%
P/E ratio23.3
Price/Sales3.31
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.02-0.10%
PTCTPTC Therapeutics Inc-1.04-1.46%
--Cosmo Pharmaceutical...+9.35+6.24%
CLVSClovis Oncology Inc+2.59+3.39%
Data as of 03/02/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts